Molecular testing service for monitoring deep response in chronic myeloid leukemia patients from diagnosis through treatment follow-up. Utilizes genomic sequencing and variant analysis to track disease progression and treatment effectiveness.
Manufactured by
Jesi, Italy
Diatech Pharmacogenetics is the Italian leader in the development, production and commercialisation of pharmacogenetics tests for cancer precision medicine. Founded in 1996, Diatech Pharmacogenetics has sustained constant organic growth over the years and now owns more than 70% of the Italian molecular diagnostic market and it is rapidly growing worldwide; to date, more than 20.000 diagnostic tests have been performed using its solutions and every year Diatech Pharmacogenetics reinvests 20% of it revenues in R D. Diatech Pharmacogenetics is able to take pharmacogenetics tests from idea to market on a variety of platforms, from real-time PCR to barcoded microarrays, mass-spectrometry and next generation sequencing, supplying all reagents, instruments, materials and support necessary. Its complete solutions guide diagnostic operators from sample extraction, quality control, molecular assay to bioinformatic analysis and report. The latest products launched include a liquid biopsy cfDNA extraction kit, a real-time PCR system with all reagent provided in a dry and stable format, micro-satellite instability assays and an end-to-end NGS solution that works on both Illumina and IonTorrent platforms. All Diatech products are developed under EN ISO 9001 and EN ISO 13485 and have been designed, developed and validated in accordance with the Directive 98/79/EC on in vitro diagnostic medical devices (CE-IVD).
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
guangzhou biotron technolongy co.,ltd
China · 3 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 5 relevant products
Lumigenex (Suzhou) Co., Ltd
China · 1 relevant product
Singlera GENOMICS (SHANGHAI) Ltd.
China · 6 relevant products
Assure Tech. (Hangzhou) Co., Ltd.
China · 3 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 1 relevant product
CheMOnitor Ltd.
Hungary · 2 relevant products
shanghai rendu biotechnology co.,ltd.
China · 1 relevant product
Acon Biotech (Hangzhou) Co., Ltd.
China · 1 relevant product
GMA Group Trading
Egypt · 2 relevant products
42 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 91 closest product alternatives
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
Lumigenex (Suzhou) Co., Ltd · China
Diagnostic test designed for chronic disease monitoring and management. Enables regular assessment of disease markers to guide ongoing patient treatment.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A liquid biopsy-based test utilizing DNA methylation markers for post-treatment cancer recurrence monitoring and surveillance. Enables early detection of disease relapse and progression.
Assure Tech. (Hangzhou) Co., Ltd. · China
Point-of-care and laboratory-based assays for screening and monitoring chronic disease biomarkers. Provides quantitative and qualitative results for disease management and follow-up.
HLB PANAGENE Co., Ltd. · South Korea
A molecular diagnostic test for BCR-ABL fusion gene detection in chronic myeloid leukemia and acute lymphoblastic leukemia.
CheMOnitor Ltd. · Hungary
An in vitro diagnostic blood test designed to predict chemotherapy effectiveness in lung cancer patients at an early stage, before full treatment cycles are completed. The test analyzes N-glycan profiles using ultra-high resolution glycomics combined with AI-based data interpretation to provide oncologists with actionable treatment response predictions.
shanghai rendu biotechnology co.,ltd. · China
Specialized molecular test for monitoring therapeutic efficacy through detection and quantification of messenger RNA. This test supports treatment response assessment and therapeutic adjustment in clinical practice.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic solution based on DNA methylation technology for identification and characterization of genetic diseases. Enables comprehensive genetic disease screening and diagnosis.
guangzhou biotron technolongy co.,ltd · China
Liquid biopsy assay for real-time monitoring of circulating tumor markers and cells during perioperative periods to assess surgical outcomes and recurrence risk.
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic assay utilizing circulating tumor cell and cell-free DNA analysis to support pulmonary nodule characterization and malignancy risk assessment.
79 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products